Treatment with recombinant human granulocyte-colony stimulating factor (G-CSF) is accepted standard for prevention of chemotherapy-induced neutropenia. RGB-02 (Gedeon Richter) is a proposed biosimilar to pegylated G-CSF (Neulasta®, Amgen) with sustained release properties. | Efficacy and safety of RGB-02 a pegfilgrastim biosimilar to prevent chemotherapy-induced neutropenia Results of a randomized double-blind phase III clinical study vs. reference pegfilgrastim in patients with breast cancer receiving chemotherapy
